ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,214.08
      0.51%
      US Tech 100
      17,660.00
      0.33%
      Dow Jones
      39,387.76
      0.85%
      Brent Oil
      84.195
      0.29%
      Bitcoin
      62,875.94
      -0.27%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Celldex Therapeutics Inc (CLDX)

      7. Celldex Therapeutics Inc (CLDX) News

      CLDX

      Celldex Therapeutics (CLDX)

      Celldex Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CLDX
      DateTimeSourceHeadlineSymbolCompany
      05/06/20244:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLDXCelldex Therapeutics Inc
      05/06/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLDXCelldex Therapeutics Inc
      05/06/20244:01PMGlobeNewswire Inc.Celldex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLDXCelldex Therapeutics Inc
      04/17/20248:01AMGlobeNewswire Inc.Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible UrticariaNASDAQ:CLDXCelldex Therapeutics Inc
      03/08/20247:00AMGlobeNewswire Inc.Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
      03/05/202410:30AMGlobeNewswire Inc.Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
      03/05/202410:10AMGlobeNewswire Inc.Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CLDXCelldex Therapeutics Inc
      03/01/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLDXCelldex Therapeutics Inc
      03/01/20244:09PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLDXCelldex Therapeutics Inc
      02/29/20249:14PMGlobeNewswire Inc.Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common StockNASDAQ:CLDXCelldex Therapeutics Inc
      02/28/20244:10PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLDXCelldex Therapeutics Inc
      02/28/20244:01PMGlobeNewswire Inc.Celldex Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:CLDXCelldex Therapeutics Inc
      02/26/20248:18AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLDXCelldex Therapeutics Inc
      02/26/20247:05AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CLDXCelldex Therapeutics Inc
      02/26/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLDXCelldex Therapeutics Inc
      02/26/20247:01AMGlobeNewswire Inc.Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLDXCelldex Therapeutics Inc
      02/24/20242:05PMGlobeNewswire Inc.Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous UrticariaNASDAQ:CLDXCelldex Therapeutics Inc
      02/15/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLDXCelldex Therapeutics Inc
      02/14/20244:17PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLDXCelldex Therapeutics Inc
      02/14/202412:52PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
      02/14/202411:48AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
      02/14/20247:38AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLDXCelldex Therapeutics Inc
      02/13/20249:41AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
      02/08/202410:11AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLDXCelldex Therapeutics Inc
      02/06/20244:01PMGlobeNewswire Inc.Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
      02/05/20248:01AMGlobeNewswire Inc.Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024NASDAQ:CLDXCelldex Therapeutics Inc
      01/04/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLDXCelldex Therapeutics Inc
      11/27/20234:15PMGlobeNewswire Inc.Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
      11/20/20234:15PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
      11/08/20235:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLDXCelldex Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:CLDX